Pathophysiology, Genetics & Classification

Question	Answer
1. What is the fundamental molecular and immunological trigger underlying the pathophysiology of Sydenham Chorea (SC)?	Sydenham Chorea is an autoimmune neuro-psychiatric disorder triggered by acute group A beta-hemolytic Streptococcus (GABHS) infection, characterized by molecular mimicry where antibodies directed against streptococcal carbohydrate or M-protein cross-react with neuronal antigens in the basal ganglia.
2. Which specific anatomical nuclei within the basal ganglia are primarily targeted by the cross-reactive antibodies in Sydenham Chorea?	The autoimmune process preferentially targets the striatum, specifically involving the caudate nucleus and putamen, which disrupts the normal inhibitory output pathways of the basal ganglia.
3. Explain the mechanism of molecular mimicry responsible for Sydenham Chorea.	Streptococcal epitopes, particularly N-acetyl-beta-D-glucosamine and M-protein, share structural homologies with human neural proteins like lysoganglioside and tubulin, leading host B and T cells to cross-react with basal ganglia neuronal surface antigens.
4. What downstream intracellular signaling cascade is activated when antineuronal antibodies bind to striatal neurons in SC?	Binding of autoantibodies to neuronal surface receptors activates calcium/calmodulin-dependent protein kinase II (CaMKII), resulting in increased dopamine and glutamate release and altered neuronal firing patterns.
5. How does the pathophysiology of Sydenham Chorea explain the characteristic motor manifestation of chorea?	Disruption of the indirect inhibitory pathway of the basal ganglia by striatal inflammation leads to a relative hyperdopaminergic state and disinhibition of the thalamocortical projections, producing random, semi-purposeless, dance-like movements.
6. Is there a known genetic inheritance pattern or specific gene mutation directly causing Sydenham Chorea?	NO. Sydenham Chorea is an acquired immune-mediated complication of streptococcal infection rather than a monogenic inherited disorder, though host genetic susceptibility factors (such as specific HLA alleles like D8/17) influence individual vulnerability.
7. What constitutes the Revised Jones Criteria classification for Acute Rheumatic Fever (ARF), and where does Sydenham Chorea fit?	Sydenham Chorea is classified as a major clinical manifestation under the revised Jones Criteria and is unique because it can appear as the sole solitary manifestation of ARF months after the primary pharyngeal infection without other preceding signs.
8. How does Sydenham Chorea fit into the broader modern classification of Pediatric Autoimmune Neuropsychiatric Disorders?	SC is considered the prototypical and definitive post-streptococcal movement disorder that inspired the conceptual framework of PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections).
9. What histopathological changes are typically found in fatal cases of Sydenham Chorea within the central nervous system?	Post-mortem examinations reveal low-grade encephalitis with perivascular lymphocytic cuffing, microglial activation, neuronal loss, and reactive astrogliosis restricted primarily to the caudate nucleus, putamen, and subthalamic nucleus.
10. Explain the clinical classification of the motor involvement pattern unique to Sydenham Chorea.	Chorea can present as generalized or as hemichorea (involving one side of the body predominantly), which reflects localized focal asymmetric immune-mediated basal ganglia inflammation.
11. What cellular pathology explains the delayed onset of chorea following a streptococcal pharyngitis episode?	The delay (typically 1 to 8 weeks) represents the time required for peripheral B-cell clonal expansion, somatic hypermutation, autoantibody generation, and subsequent blood-brain barrier penetration by circulating antineuronal antibodies and lymphocytes.
12. VIVA TRAP: Can Sydenham Chorea be diagnosed definitively by finding elevated anti-streptolysin O (ASO) titers alone?	NEVER. ASO and anti-DNase B titers only confirm a recent streptococcal infection; the diagnosis of Sydenham Chorea is primarily clinical, supported by excluding other etiologies, as antibody titers may have already peaked and begun falling by the time chorea manifests.
13. What is the pathological explanation for the hypotonia and "milk-maid sign" observed in patients with SC?	Striatal dysfunction impairs the basal ganglia's modulation of muscle tone and postural control, resulting in fluctuating muscle contractions (milk-maid grip) and generalized hypotonia due to diminished thalamocortical facilitation.
14. How does the blood-brain barrier (BBB) integrity contribute to the pathophysiology of central nervous system involvement in SC?	Transient or localized alterations in BBB permeability, possibly induced by systemic inflammation and vascular adhesion molecule expression, permit circulating antineuronal antibodies to gain access to the basal ganglia parenchyma.
15. What neuropsychiatric disturbances commonly accompany chorea and share the same basal ganglia pathophysiological mechanism?	Obsessive-compulsive disorder (OCD), emotional lability, anxiety, and attention-deficit/hyperactivity disorder (ADHD) frequently accompany SC because the frontostriatal circuits controlling behavioral inhibition and mood regulation course through the exact same affected striatal regions.
16. How is the severity of Sydenham Chorea clinically graded or classified for management decisions?	Severity is typically graded clinically as mild (no functional impairment, mild fidgetiness), moderate (interferes with daily activities, independent ambulation possible), or severe (housebound, bedridden, requiring assistance for feeding and nursing care, or complicated by severe choreic injury).
17. VIVA TRAP: Does the presence of chorea in a patient with a history of rheumatic fever always mean active carditis is present?	NO. Sydenham Chorea can occur entirely in isolation as a delayed manifestation of ARF without concurrent clinical or echocardiographic evidence of active rheumatic carditis or arthritis.
18. What role do T-cells play alongside B-cells in the neuro-inflammatory cascade of SC?	CD4+ T-helper cells infiltrate the basal ganglia alongside antibody-secreting B-cells, promoting local cytokine release (such as tumor necrosis factor-alpha and interleukins) that amplifies neuroinflammation and neuronal dysfunction.
19. What is the classic term used for the abrupt, irregular, non-rhythmic involuntary tongue movements described in SC, and what causes them?	The "jack-in-the-box tongue" (or bag of worms tongue) occurs due to involuntary, uncoordinated motor unit activation of the intrinsic and extrinsic tongue musculature controlled by the affected extrapyramidal system.
20. Why does Sydenham Chorea typically follow a self-limiting disease course despite its acute autoimmune onset?	The autoimmune response is generally self-limiting as peripheral immune tolerance is re-established over time following clearance of the initial streptococcal trigger, leading to spontaneous resolution within weeks to months (though recurrences can happen).

Clinical History & Bedside Evaluation

Question	Answer
1. What is the typical peak age and gender distribution for children presenting with Sydenham Chorea in clinical practice?	Sydenham Chorea most frequently affects children between 5 and 15 years of age, with a distinct female predilection showing a female-to-male ratio of roughly 2:1.
2. How does the chronological progression of symptoms typically unfold from the initial inciting streptococcal infection to the appearance of choreic movements?	There is a classic latent period of 1 to 6 weeks between the acute Group A Beta-Hemolytic Streptococcal (GABHS) pharyngitis and the onset of neurological signs, by which time throat cultures have often become negative and anti-streptococcal titers may be waning.
3. In taking a focused dietary and environmental history, what specific social and domestic factors must be actively probed for a child suspected of having Sydenham Chorea?	The examiner must inquire about overcrowding, low socioeconomic status, shared sleeping quarters, and recent outbreaks of sore throat or scarlet fever within the family or school, as these are major risk factors for GABHS transmission.
4. What specific details must be elicited during the perinatal and early developmental history in a child presenting with acute chorea?	Perinatal and developmental histories are typically entirely normal in Sydenham Chorea; a history of early-onset neurodevelopmental delay or static encephalopathy points instead toward hereditary or congenital choreas.
5. How does constructing a detailed family pedigree help differentiate Sydenham Chorea from other pediatric movement disorders?	A positive family history of chorea spanning multiple generations strongly suggests an autosomal dominant inherited condition like Huntington's Disease or Benign Hereditary Chorea rather than sporadic Sydenham Chorea.
6. What historical red flags would immediately steer the clinician away from Sydenham Chorea and toward a metabolic or neurodegenerative differential diagnosis?	Red flags include neonatal onset, rapid global regression, regression of vision, seizures, prominent dystonia as the primary presenting sign, or lack of any antecedent infectious history.
7. During the history taking, what subtle academic or behavioral changes reported by parents or teachers often precede the overt motor manifestations of Sydenham Chorea?	Parents and teachers frequently report sudden scholastic decline, handwriting deterioration, emotional lability, irritability, and hyperactivity that are later recognized as early manifestations of chorea and associated neuropsychiatric symptoms.
8. Why is a meticulous history of preceding cutaneous or pharyngeal infections crucial, and why might it yield negative microbiological results at the time of evaluation?	A history of untreated pharyngitis or impetigo establishes the prior GABHS exposure; however, because of the long latent interval, throat cultures are negative in up to 75% of patients by the time chorea emerges.
9. How does the mode of onset—acute versus insidious—help in the clinical evaluation of a child presenting with involuntary movements?	Sydenham Chorea classically presents with a subacute or relatively abrupt onset over days to weeks, whereas genetic or metabolic choreas typically manifest with an insidious, slowly progressive onset.
10. What historical clues regarding medication exposure must be explicitly ruled out before finalizing a diagnosis of Sydenham Chorea?	The clinician must review the medication history to exclude drug-induced chorea caused by exposure to neuroleptics, stimulants, anticonvulsants (like phenytoin or carbamazepine), or oral contraceptives.
11. VIVA TRAP: Is a documented history of a clinically apparent sore throat mandatory to make a clinical diagnosis of Sydenham Chorea?	NO. Up to 30% of patients with Sydenham Chorea have a clinically silent or completely unremembered preceding GABHS infection, making the diagnosis entirely tenable without a documented history of pharyngitis.
12. What historical screening questions should be asked to uncover the subclinical cardiac involvement frequently associated with Sydenham Chorea?	The examiner must ask about exertional dyspnea, orthopnea, palpitations, or exercise intolerance, as subclinical rheumatic carditis accompanies chorea in a significant percentage of patients.
13. How should a thorough past medical history address previous episodes of rheumatic fever in evaluating a new presentation of chorea?	The clinician must actively ask about prior migratory polyarthritis, erythema marginatum, or subcutaneous nodules, which would fulfill the Jones criteria and confirm a broader acute rheumatic fever syndrome.
14. What specific occupational or daily living history questions help quantify the functional impairment caused by choreic movements during bedside evaluation?	The examiner should inquire about the child's ability to feed themselves, button clothes, write, hold a cup without spilling, and walk without falling, which reflect the functional severity of the motor disorder.
15. Why is it clinically vital to take a detailed psychiatric and behavioral history alongside the motor evaluation in suspected Sydenham Chorea?	Emotional lability, obsessive-compulsive symptoms, and attention-deficit hyperactivity disorder (ADHD) often co-exist or even precede the motor signs due to shared basal ganglia pathology.
16. VIVA TRAP: Can a history of vaccination in the preceding weeks be considered a primary etiological risk factor for developing Sydenham Chorea?	NEVER. Sydenham Chorea is specifically linked to Group A Beta-Hemolytic Streptococcal infections and acute rheumatic fever; routine immunizations do not trigger this autoimmune cascade.
17. What specific questions should be directed toward identifying the "jack-in-the-box" tongue or "milk-maid" grip during the preliminary functional history?	The clinician can ask if the child drops objects unexpectedly or if family members have noticed the child biting their tongue or having difficulty keeping the tongue protruded.
18. How does the geographic and ethnic background obtained in the demographic history influence the pre-test probability of Sydenham Chorea?	Sydenham Chorea is significantly more prevalent in developing nations, low-resource settings, and specific indigenous populations where overcrowding facilitates high rates of untreated GABHS infections.

Physical Examination & Bedside Signs

Question	Answer
1. What is the classic bedside demonstration for eliciting muscle hypotonia and transient grip weakness in Sydenham Chorea known as the "milk-maid's sign"?	1. Ask the patient to squeeze the examiner's index and middle fingers continuously. 2. Observe and feel alternating involuntary contractions and relaxations of the patient's grip strength, resembling the rhythmic action of milking a cow.
2. How do you elicit and evaluate the "jack-in-the-box" sign (or chameleon tongue) during the physical examination of a patient with Sydenham Chorea?	1. Ask the patient to protrude their tongue fully and keep it out. 2. Observe the sudden, involuntary darting or snapping of the tongue in and out of the mouth, often accompanied by irregular writhing movements, caused by intrinsic lingual muscle chorea.
3. What is Gordon's sign, and how is it elicited at the bedside in a patient suspected of Sydenham Chorea?	1. Gordon's sign is an abnormal sustained posture or delayed relaxation of muscle contraction. 2. When the examiner tests the knee jerk, the lower leg may remain extended or swing abnormally back and forth (pendular knee jerk) due to profound hypotonia and impaired antagonist motor control.
4. Describe the physical examination maneuver used to elicit Pronator Sign (or "choreic hands") in Sydenham Chorea.	1. Instruct the patient to hold their arms extended forward overhead with palms facing upward and fingers spread. 2. Observe for involuntary pronation of the forearms and flexion of the wrists, alongside hyperextension of the metacarpophalangeal joints (the "spooning" deformity).
5. What is "trombone tongue" or the lingual manifestation seen on inspection during the oral examination of a choreic child?	1. It is characterized by rapid, continuous protrusion and retraction of the tongue into and out of the oral cavity. 2. It interferes with articulation and feeding, resembling the movement of a trombone slide.
6. How does the examiner assess for "hung-up" reflexes during standard neurological examination of deep tendon reflexes?	1. Tap the patellar tendon to elicit the knee jerk. 2. Observe a pendular reflex where the leg swings multiple times, or note a delayed relaxation phase where the limb remains elevated or delayed in returning to rest.
7. What characteristic gait abnormalities will you observe during the ambulatory inspection of a child with severe Sydenham Chorea?	1. A dance-like, erratic, and uncoordinated gait ("choreic gait") characterized by sudden interruptions, unexpected lunges, and exaggerated movements of the limbs. 2. The child may cross their legs (scissoring) or lurch unpredictably while walking.
8. How can you demonstrate truncal and facial instability (the "dancing face and trunk") during quiet standing?	1. Have the patient stand with feet together and eyes closed (modified Romberg or quiet stance). 2. Observe random, fleeting grimacing, eyebrow raising, tongue darting, and truncal swaying that cannot be suppressed voluntarily for long.
9. What specific physical finding is revealed when the patient is asked to maintain posture against resistance, demonstrating motor impersistence?	1. The patient cannot sustain a steady muscular contraction or posture, such as keeping the eyes squeezed shut, tongue protruded, or grip maintained. 2. The contraction intermittently wanes and surges unpredictably.
10. Describe the bedside assessment of fine motor dexterity and handwriting abnormalities in mild Sydenham Chorea.	1. Ask the patient to write a sentence or draw a spiral. 2. The handwriting appears erratic, large, uncoordinated (graphospasm), with jerky pen strokes, sudden interruptions, and frequent slips outside boundaries.
11. What cardiac auscultation findings must you actively search for during the physical examination, given the high association with rheumatic carditis?	1. An apical holosystolic murmur radiating to the axilla indicating mitral regurgitation, or an early diastolic decrescendo murmur at the left sternal border indicating aortic regurgitation. 2. A high-pitched apical mid-diastolic murmur (Carey Coombs murmur) pointing to active valvulitis.
12. VIVA TRAP: Can the involuntary movements of Sydenham Chorea be completely suppressed by conscious effort during a formal neurological examination?	NO. While patients may briefly suppress or incorporate choreic movements into semi-purposeful actions (motor parry), they cannot be fully or permanently suppressed, and attempts at suppression worsen generalized restlessness.
13. How do you differentiate the hypotonia of Sydenham Chorea from cerebellar hypotonia during passive limb manipulation?	1. In Sydenham Chorea, hypotonia is accompanied by random, flowing, involuntary choreic bursts that interrupt passive range of motion. 2. Cerebellar hypotonia shows pendular reflexes and rebound phenomenon without superimposed involuntary writhing movements.
14. What physical sign is elicited when the patient attempts to grasp the examiner's hand and exhibits irregular waxing and waning of pressure?	1. This is the classic milk-maid's sign (or sign of the milking hand), reflecting impaired motor unit recruitment and alternating hypotonia with involuntary muscle spasms.
15. VIVA TRAP: Are deep tendon reflexes always diminished or hyporeflexic in every patient diagnosed with Sydenham Chorea?	NO. While hypotonia and pendular reflexes are classic, deep tendon reflexes can sometimes be normal or difficult to assess accurately due to the continuous superimposition of choreic muscle contractions.
16. How does the "spooning" of the hands manifest when a patient with Sydenham Chorea is asked to hold their arms outstretched?	1. Hyperextension of the metacarpophalangeal joints and flexion of the wrists and fingers, resembling the shape of a spoon, caused by distal postural muscle imbalance.
17. What bedside observation confirms that the involuntary movements completely disappear during sleep?	1. Observing the child while sleeping reveals total cessation of choreic movements, which is a hallmark clinical feature distinguishing chorea from other organic movement disorders like myoclonus or tics.
18. How is the presence of subclinical carditis evaluated at the bedside when auscultation is completely normal?	1. Bedside physical examination cannot detect subclinical carditis; an immediate emergency bedside or formal echocardiogram with color Doppler is mandatory to detect silent mitral or aortic regurgitation.

Diagnostic Criteria & Investigations

Question	Answer
1. What is the role of anti-streptolysin O (ASO) and anti-deoxyribonuclease B (anti-DNase B) titers in confirming a diagnosis of Sydenham Chorea?	1. Elevated titers indicate a recent Group A Streptococcus infection, supporting the post-streptococcal etiology. 2. However, they may have already peaked and begun declining by the time chorea manifests weeks to months later. 3. Thus, normal titers do not exclude the diagnosis if the clinical presentation is classic.
2. According to the revised Jones criteria, is microbiological confirmation via throat culture or rapid antigen test mandatory for diagnosing Sydenham Chorea?	1. NO. Throat culture and rapid antigen tests are frequently negative by the time neurological symptoms appear because the latent period is prolonged. 2. Diagnosis relies heavily on the characteristic clinical phenotype and exclusion of other causes, even in the absence of acute throat swab positivity.
3. What is the diagnostic significance of a positive throat culture or elevated streptococcal antibody titer in an isolated case of pediatric chorea?	1. They merely establish antecedent Group A Streptococcal exposure, not a definitive causal link. 2. The clinician must still fulfill diagnostic criteria and rigorously rule out Wilson disease, systemic lupus erythematosus, and neurodegenerative disorders before labeling it Sydenham Chorea.
4. What routine laboratory panel is mandatory to exclude Wilson disease as a primary differential diagnosis for acute chorea in school-aged children?	1. Serum ceruloplasmin levels (typically markedly decreased in Wilson disease). 2. 24-hour urinary copper excretion. 3. Slit-lamp examination for Kayser-Fleischer rings.
5. Why is baseline echocardiography with Doppler evaluation mandatory in every newly diagnosed case of Sydenham Chorea?	1. Up to 60-80% of patients with Sydenham Chorea have subclinical or clinical rheumatic carditis. 2. Echocardiography detects morphological and Doppler-derived evidence of mitral and aortic regurgitation even when auscultation is completely normal.
6. What are the characteristic neuroimaging (MRI brain) findings in a typical uncomplicated case of Sydenham Chorea?	1. MRI brain is usually normal in the majority of uncomplicated cases. 2. When abnormalities are present, they may transiently show T1 hyperintensity or T2/FLAIR hyperintensity involving the contralateral basal ganglia (caudate nucleus and putamen).
7. VIVA TRAP: Is routine neuroimaging (CT or MRI brain) mandatory to confirm the diagnosis of Sydenham Chorea in a child with classic clinical features?	1. NO. Neuroimaging is primarily indicated to rule out structural, vascular, or metabolic stroke-like mimics when the presentation is atypical or focal, rather than to confirm classic Sydenham Chorea.
8. What specific autoimmune panel must be ordered if Systemic Lupus Erythematosus (SLE) is suspected in the differential diagnosis of pediatric chorea?	1. Antinuclear antibodies (ANA). 2. Anti-double-stranded DNA (anti-dsDNA) antibodies. 3. Antiphospholipid antibodies (lupus anticoagulant, anticardiolipin, and anti-beta-2-glycoprotein I antibodies).
9. How do cerebrospinal fluid (CSF) findings typically appear in a patient with uncomplicated Sydenham Chorea?	1. CSF analysis is generally normal and is not routinely required unless an infectious or inflammatory encephalitis/encephalomyelitis is suspected in the differential diagnosis.
10. What is the diagnostic utility of Electroencephalography (EEG) in evaluating a child presenting with Sydenham Chorea?	1. EEG is usually non-specific, showing mild generalized slowing or disorganized background rhythms related to diffuse subcortical dysfunction. 2. It is primarily useful if subclinical focal or generalized seizure activity is suspected as a differential diagnosis.
11. VIVA TRAP: Does a negative anti-streptolysin O (ASO) titer completely rule out Sydenham Chorea?	1. NEVER. ASO titers rise within 3 to 5 weeks post-infection and fall slowly; by the time chorea appears (often 1 to 6 months later), ASO titers may have returned entirely to baseline, making anti-DNase B a more persistent marker, but clinical judgment overrides single negative antibody tests.
12. What hematological and inflammatory biomarker cutoffs are typically evaluated in suspected acute rheumatic fever with chorea, and are they always elevated?	1. Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) are acute-phase reactants. 2. While elevated in acute arthritis or carditis, they are frequently normal or only minimally elevated by the time Sydenham Chorea presents due to the long latency period.
13. How does functional neuroimaging (such as PET or SPECT scans) help elucidate the pathophysiology of Sydenham Chorea during active phases?	1. They often demonstrate hyperperfusion or hypermetabolism within the contralateral basal ganglia structures (striatum). 2. However, these specialized nuclear imaging modalities remain strictly investigational and are not utilized in routine clinical diagnostic criteria.
14. What specific blood test must be performed to rule out a common genetic neurometabolic mimic of chorea presenting in early childhood (Benign Hereditary Chorea)?	1. Genetic testing for mutations in the TITF1/NKX2-1 gene. 2. Routine metabolic panels, serum amino acids, and urine organic acids are also used to exclude other neurometabolic storage and mitochondrial disorders.
15. In evaluating Sydenham Chorea, how do criteria distinguish between primary chorea and Sydenham Chorea secondary to Sydenham-like post-streptococcal autoimmune encephalitis (PANDAS)?	1. Sydenham Chorea is an established post-streptococcal manifestation of acute rheumatic fever fitting the Jones criteria. 2. PANDAS remains a debated clinical entity defined by obsessive-compulsive disorder and/or tic disorders exacerbated by streptococcal infections, lacking the classic motor chorea and carditis features.
16. What diagnostic clues on laboratory evaluation help differentiate Sydenham Chorea from Sydenham-like chorea induced by drug toxicity or antiepileptic medications?	1. Toxicological screening (urine drug screen) and serum drug levels (e.g., phenytoin, carbamazepine, lithium) will be positive or elevated in drug-induced chorea, whereas inflammatory markers and streptococcal titers follow an independent pattern in Sydenham Chorea.
17. VIVA TRAP: Can a single elevated ASO titer in an asymptomatic child confirm that their new-onset movement disorder is definitely Sydenham Chorea?	1. NO. Elevated streptococcal titers are common in normal school-aged children due to high rates of asymptomatic pharyngeal carriage in the community; titers must be interpreted strictly within the full clinical context.
18. What specific endocrinological screening test is sometimes included in the baseline workup of acute chorea to rule out metabolic imbalances?	1. Serum electrolytes, calcium, and magnesium levels to rule out hypocalcemia or electrolyte disturbances that can trigger involuntary hyperkinetic movements. 2. Thyroid function tests (TSH and free T4) to exclude thyrotoxicosis-induced chorea.
19. What is the fundamental principle governing the diagnostic workup of acute pediatric chorea according to modern pediatric neurology guidelines?	1. Exclude life-threatening, treatable, or genetic mimics first (e.g., Wilson disease, SLE, structural brain lesions, drug toxicity). 2. Confirm antecedent streptococcal exposure via serology and assess cardiac involvement via echocardiography to establish the diagnosis of Sydenham Chorea.

Evidence-Based Management & Pharmacotherapy

Question	Answer
1. Which first-line antimicrobial agent and regimen are recommended for eradicating group A streptococcus upon diagnosis of Sydenham Chorea?	A single intramuscular injection of Benzathine Penicillin G (1.2 million units for weight >27 kg, or 600,000 units if ≤27 kg) is administered, or a 10-day course of oral penicillin V or amoxicillin if penicillin allergy is absent.
2. What is the standard duration of secondary antibiotic prophylaxis in a patient with Sydenham Chorea who has no evidence of rheumatic carditis?	Prophylaxis must be continued at least until the patient reaches 21 years of age or for a minimum of 10 years from the onset of the attack, whichever is longer, and often lifelong if cardiac involvement is present.
3. Which dopamine-depleting agent is considered first-line for moderate-to-severe symptomatic suppression of choreic movements?	Tetrabenazine is utilized, starting at a low dose of 12.5 mg/day divided twice daily and slowly titrated upward by 12.5 mg weekly based on clinical response and tolerability.
4. What is the precise mechanism of action of Tetrabenazine in ameliorating chorea?	It reversibly inhibits vesicular monoamine transporter 2 (VMAT2), decreasing presynaptic dopamine uptake into synaptic vesicles and depleting central monoamine stores.
5. What life-threatening side effect must clinicians actively monitor for when treating a pediatric patient with Tetrabenazine?	Severe drug-induced depression with suicidal ideation, extrapyramidal symptoms including parkinsonism, and akathisia require rigorous psychiatric and neurological surveillance.
6. Which atypical antipsychotic agent serves as an alternative first-line or adjunctive medication for suppressing severe chorea and managing associated behavioral lability?	Risperidone, initiated at 0.25 to 0.5 mg daily and titrated slowly, is frequently preferred due to its efficacy and lower risk of tardive dyskinesia compared to typical neuroleptics.
7. What specific laboratory monitoring is mandatory when initiating and maintaining therapy with Valproic Acid in pediatric chorea?	Regular monitoring of liver function tests (LFTs), serum total or free valproate levels, complete blood count with platelets, and clinical surveillance for pancreatitis or hepatotoxicity is required.
8. When are corticosteroids (such as Prednisolone or intravenous Methylprednisolone pulses) indicated in the management of Sydenham Chorea?	Corticosteroids are reserved for severe, disabling, or refractory cases of chorea, or when carditis or encephalopathy coexists, to suppress the underlying autoimmune neuroinflammation.
9. VIVA TRAP: Can dopamine receptor antagonists like Haloperidol be used indefinitely as maintenance therapy for Sydenham Chorea once movements are controlled?	NEVER. Typical neuroleptics like haloperidol should only be used for short-term acute control due to the high risk of irreversible tardive dyskinesia and severe extrapyramidal side effects.
10. What specific clinical and laboratory parameter must be monitored weekly during the upward titration phase of Tetrabenazine therapy?	Assessment for depressive symptoms using standardized rating scales, monitoring of blood pressure for orthostatic hypotension, and evaluation for excessive somnolence or parkinsonian rigidity.
11. How should pharmacotherapy for chorea be discontinued once the acute natural history of Sydenham Chorea runs its course?	Anti-chorea medications should be gradually tapered and discontinued over several weeks to months, typically after 3 to 6 months when clinical remission is clinically evident.
12. What adjunctive pharmacotherapy is indicated if a child with Sydenham Chorea develops severe obsessive-compulsive symptoms (OCS) or emotional lability?	Selective serotonin reuptake inhibitors (SSRIs) such as Sertraline or Fluoxetine, combined with cognitive behavioral therapy, form the cornerstone of management for comorbid OCS.
13. VIVA TRAP: Is therapeutic plasma exchange (plasmapheresis) indicated as a routine first-line intervention for a newly diagnosed, mild case of Sydenham Chorea?	NO. Plasmapheresis is strictly restricted to severe, life-threatening, or encephalopathic cases refractory to all conventional immunomodulatory therapies and high-dose steroids.
14. What critical cardiac surveillance guideline must be paired with neurological pharmacotherapy management in every Sydenham Chorea patient?	Serial echocardiograms must be performed periodically (every 6 to 12 months, or as dictated by carditis severity) to monitor the progression or regression of rheumatic valvular lesions.
15. What specific multidisciplinary rehabilitation therapies must be integrated into the acute and convalescent pharmacotherapy plan of a child with severe chorea?	Physical therapy for gait training and postural stability, occupational therapy for fine motor adaptation, and speech-language therapy for swallowing and dysarthria support are essential components.
16. VIVA TRAP: Can intravenous immunoglobulin (IVIG) be routinely administered as first-line monotherapy for all mild cases of Sydenham Chorea at the time of presentation?	NO. IVIG is reserved exclusively for severe, refractory, or debilitating cases of Sydenham Chorea that fail to respond adequately to standard symptomatic agents (such as tetrabenazine or valproic acid) and immune modulators like corticosteroids, rather than serving as routine first-line therapy for mild presentations.

High-Yield VIVA TRAPs & Examiner Pitfalls

Question	Answer
1. VIVA TRAP: Is chorea in Sydenham Chorea present during deep sleep and does it worsen under emotional stress or voluntary action?	NO. Chorea characteristically disappears entirely during sleep and typically worsens with emotional stress, fatigue, or voluntary attempts at movement, and lessens with absolute rest.
2. VIVA TRAP: What pathognomonic speech disturbance often accompanies moderate-to-severe Sydenham Chorea due to involuntary movements of the tongue, lips, and respiratory muscles?	'Choreic speech' or explosive, erratic dysarthria, characterized by sudden interruptions of speech or unpredictable changes in volume and cadence.
3. VIVA TRAP: Can permanent structural brain damage or fixed intellectual disability be expected as a standard long-term sequela of uncomplicated Sydenham Chorea?	NO. Sydenham Chorea is fundamentally a self-limiting, non-destructive autoimmune encephalitis; long-term motor and cognitive recovery is typically complete, though transient behavioral or psychiatric sequelae may persist.
4. VIVA TRAP: What is the classic behavioral syndrome that frequently precedes or accompanies the onset of motor symptoms in Sydenham Chorea?	Emotional lability, personality changes, severe anxiety, and obsessive-compulsive symptoms (often referred to as Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections, or PANDAS-like spectrum features).
5. VIVA TRAP: Should therapeutic management of Sydenham Chorea include the immediate prescription of levodopa-carbidopa to correct basal ganglia dysfunction?	NEVER. Levodopa increases central dopamine availability and would drastically worsen choreic movements, as Sydenham Chorea involves relative hyperdopaminergic activity within the basal ganglia circuitry.
6. VIVA TRAP: What specific clinical phenomenon occurs when a patient attempts to maintain sustained tongue protrusion, reflecting striatal involvement?	The 'jack-in-the-box' tongue or 'darting tongue' sign, where the tongue is protruded involuntarily but cannot be held steady, snapping back into the mouth immediately.
7. VIVA TRAP: Can a patient with Sydenham Chorea safely participate in contact sports or competitive physical education while experiencing active, moderate choreic movements?	NEVER. Active chorea severely impairs coordination and postural reflexes, placing the child at extreme risk for traumatic injury, falls, and joint trauma; strict physical rest is mandatory.
8. VIVA TRAP: Are physical restraints or padding of side rails indicated as standard daily management for a child with mild facial and distal limb chorea?	NO. Physical restraints exacerbate agitation and emotional lability; they are reserved strictly as an absolute last resort for self-injurious, severe, hyperkinetic states unresponsive to heavy sedation.
9. VIVA TRAP: What specific occupational therapy assessment is essential to gauge functional independence in a child recovering from acute Sydenham Chorea?	Fine motor function tests assessing writing, buttoning clothes, self-feeding, and holding cups, as distal limb chorea severely disrupts activities of daily living.
10. VIVA TRAP: Can a single negative throat swab at the time of neurological presentation completely exclude a preceding streptococcal infection?	NO. By the time neurological symptoms of Sydenham Chorea manifest weeks after the initial pharyngitis, the pharyngeal streptococcal load has often cleared spontaneously, resulting in negative throat cultures.
11. VIVA TRAP: What subtle oculomotor abnormality can sometimes be elicited during smooth pursuit testing in patients with active Sydenham Chorea?	Saccadic intrusions during smooth pursuit eye movements, reflecting impaired basal ganglia and cerebellar control over voluntary gaze.
12. VIVA TRAP: Can a clinician safely prescribe traditional phenothiazine antiemetics like prochlorperazine to manage nausea in a child recovering from Sydenham Chorea?	NEVER. Phenothiazines are potent dopamine receptor antagonists that can trigger severe acute dystonic reactions or exacerbate baseline extrapyramidal dysfunction in a brain already sensitized by Sydenham Chorea.
13. VIVA TRAP: Is it appropriate to initiate high-dose stimulant therapy (such as methylphenidate) if a child with Sydenham Chorea exhibits persistent academic underperformance and inattention during convalescence?	NEVER. Central nervous system stimulants enhance dopaminergic neurotransmission and can dramatically provoke or worsen choreiform movements and underlying behavioral lability.
14. VIVA TRAP: Should clinicians utilize long-term benzodiazepine monotherapy as the primary disease-modifying treatment to halt the autoimmune destruction of basal ganglia neurons in Sydenham Chorea?	NO. Benzodiazepines only offer temporary symptomatic sedation and GABAergic dampening; they possess zero disease-modifying or immunomodulatory efficacy against the underlying post-streptococcal autoimmune process.
15. VIVA TRAP: Can routine screening for Sydenham Chorea rely exclusively on obtaining a standard 12-lead electrocardiogram without performing a formal echocardiogram?	NO. An ECG cannot reliably exclude subclinical rheumatic carditis; comprehensive evaluation mandates a color Doppler echocardiogram because subclinical valvulitis frequently accompanies Sydenham Chorea.
16. VIVA TRAP: Is routine lumbar puncture mandatory to confirm the diagnosis in every classic, straightforward presentation of Sydenham Chorea?	NO. Sydenham Chorea is a clinical diagnosis supported by evidence of preceding streptococcal infection; CSF analysis is reserved exclusively for atypical presentations to rule out infectious or inflammatory encephalitis.
17. VIVA TRAP: Can secondary antibiotic prophylaxis be safely discontinued in a patient with Sydenham Chorea as soon as the involuntary choreic movements have completely resolved?	NEVER. Secondary prophylaxis must be continued strictly based on rheumatic fever guidelines (often until age 21 or 10 years post-attack) regardless of whether chorea has completely resolved, to prevent recurrent carditis.